MECCELLIS BIOTECH Trademark
Trademark Overview
On Friday, February 24, 2023, a trademark application was filed for MECCELLIS BIOTECH with the United States Patent and Trademark Office. The USPTO has given the MECCELLIS BIOTECH trademark a serial number of 97811519. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 11, 2024. This trademark is owned by MECCELLIS BIOTECH. The MECCELLIS BIOTECH trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for preventing infection during tissue regeneration of breast, thoracic, digestive, pelvic, plastic surgery and for human tissue repair, regeneration or strengthening; biological and surgical implants derived from living tissue, namely, skin tissue, acellular dermal matrix and resorbing biopolymer intended for subsequent implantation; biological skin tissue implants intended for breast, thoracic, digestive, pelvic and plastic surgery; biological skin tissue implants intended for human tissue repair, regeneration or strengthening; acellular matrices in the nature of biological skin tissue used as implants intended for surgery; biological skin tissue matrices for human tissue repair, regeneration or strengthening
Research and development of new products in the field of medical devices, biomaterials and pharmaceuticals; Research and development of new products in the field of biological and surgical implants; Surgical and medical research; Medical and surgical research relating to the repair, regeneration and strengthening of tissue; Tissue and cell engineering; Research in the field of reconstructive plastic surgery and repair of damaged or ruptured soft tissue membranes
General Information
| Serial Number | 97811519 |
| Word Mark | MECCELLIS BIOTECH |
| Filing Date | Friday, February 24, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, June 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 16, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for preventing infection during tissue regeneration of breast, thoracic, digestive, pelvic, plastic surgery and for human tissue repair, regeneration or strengthening; biological and surgical implants derived from living tissue, namely, skin tissue, acellular dermal matrix and resorbing biopolymer intended for subsequent implantation; biological skin tissue implants intended for breast, thoracic, digestive, pelvic and plastic surgery; biological skin tissue implants intended for human tissue repair, regeneration or strengthening; acellular matrices in the nature of biological skin tissue used as implants intended for surgery; biological skin tissue matrices for human tissue repair, regeneration or strengthening |
| NOT AVAILABLE | "BIOTECH" |
| Translation of Words in Mark | The wording "MECCELLIS" has no meaning in a foreign language. |
| Goods and Services | Research and development of new products in the field of medical devices, biomaterials and pharmaceuticals; Research and development of new products in the field of biological and surgical implants; Surgical and medical research; Medical and surgical research relating to the repair, regeneration and strengthening of tissue; Tissue and cell engineering; Research in the field of reconstructive plastic surgery and repair of damaged or ruptured soft tissue membranes |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 16, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 16, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | MECCELLIS BIOTECH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | 17000 LA ROCHELLE -
FR |
| Party Name | MECCELLIS BIOTECH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | 17000 LA ROCHELLE -
FR |
Trademark Events
| Event Date | Event Description |
| Tuesday, February 28, 2023 | NEW APPLICATION ENTERED |
| Thursday, March 16, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 24, 2023 | ASSIGNED TO EXAMINER |
| Monday, November 27, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, November 27, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, November 27, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, February 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, February 27, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 27, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 1, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Monday, March 11, 2024 | ELECTRONIC RECORD REVIEW COMPLETE |
| Wednesday, March 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 16, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 11, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, November 20, 2024 | TEAS DELETE 1(B) BASIS RECEIVED |
